Timeline
T-Therapeutics
Cambridge biotech making T-cell receptor bispecifics; raised a $133m Series B in November 2026.
2 of 2 entries (2 events, 0 interactions)
Filters
#17 10 Nov
Mentioned in: Oyster brings Eli Lilly into $60m round
UK Startups and Innovation#17 5 Nov